Posit Science Pushes for Science-Backed Alzheimer’s Prevention on World Alzheimer’s Day — Posit Science Corporation (BrainHQ)

Event summary

Posit Science’s BrainHQ calls for shift from general Alzheimer’s awareness to proven prevention strategies on World Alzheimer’s Day 2026.
CEO Dr. Henry Mahncke cites meta-analysis in Lancet 2025 showing only physical exercise and cognitive training significantly improve global cognition.
BrainHQ highlights three key studies (INHANCE, ACTIVE, ENACT) demonstrating cognitive training’s impact on Alzheimer’s biomarkers and incidence.
BrainHQ has shown benefits in over 300 studies, including improvements in cognition, quality of life, and real-world activities.

The big picture

Posit Science’s push for science-backed Alzheimer’s prevention aligns with the broader shift in healthcare toward personalized, evidence-based interventions. As global dementia cases rise, the demand for proven cognitive training solutions like BrainHQ is likely to grow, positioning the company at the forefront of a critical market segment. The company’s strategic emphasis on clinical validation could set a new standard for the industry, potentially reshaping how cognitive health is managed and prevented.

What we're watching

Clinical Validation: How the growing body of evidence for BrainHQ’s efficacy will impact adoption by health plans and medical centers.
Market Differentiation: Whether BrainHQ can sustain its lead in neuroplasticity-based training as competitors enter the space with similar claims.
Regulatory Dynamics: The pace at which regulatory bodies may recognize and endorse cognitive training as a standard preventive measure for Alzheimer’s.